Search research articles
Contact Us
Filters
Showing results (761-770 of 1,104) with videos related to
Page
of 111
Sort By:
Psychological Review
|
February 6, 2004
Structure and deterioration of semantic memory: a neuropsychological and computational investigation
Timothy T Rogers, Matthew A Lambon Ralph, Peter Garrard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 15, 2005
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia
Shibley Rahman, Trevor W Robbins, John R Hodges, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 15, 2014
New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
Leone Chare, John R Hodges, Cristian E Leyton, et al.
Journal of Spinal Disorders & Techniques
|
January 21, 2014
Impact of subsidence on clinical outcomes and radiographic fusion rates in anterior cervical discectomy and fusion: a systematic review
Isaac O Karikari, Deeptee Jain, Timothy Ryan Owens, et al.
Neuroimage. Clinical
|
November 2, 2013
Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions
Muireann Irish, Emma Devenney, Stephanie Wong, et al.
Mucosal Immunology
|
April 14, 2016
Lipoxin A<sub>4</sub> activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion
R R Hodges, D Li, M A Shatos, et al.
Mucosal Immunology
|
July 2, 2015
Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function
L García-Posadas, R R Hodges, D Li, et al.
Frontiers in Immunology
|
September 20, 2021
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
Fiona Bright, Jared S Katzeff, John R Hodges, et al.
Antimicrobial Agents and Chemotherapy
|
March 29, 2024
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants
Michael R Hodges, Susan Hazel, William G Kramer, et al.
JAMA Neurology
|
October 21, 2014
Quantifying the eating abnormalities in frontotemporal dementia
Rebekah M Ahmed, Muireann Irish, Jonathan Kam, et al.
Page
of 111
Search research articles
Search
Showing results (761-770 of 1,104) with videos related to
Sort By:
Page
of 111
Psychological Review
|
February 6, 2004
Structure and deterioration of semantic memory: a neuropsychological and computational investigation
Timothy T Rogers, Matthew A Lambon Ralph, Peter Garrard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 15, 2005
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia
Shibley Rahman, Trevor W Robbins, John R Hodges, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 15, 2014
New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
Leone Chare, John R Hodges, Cristian E Leyton, et al.
Journal of Spinal Disorders & Techniques
|
January 21, 2014
Impact of subsidence on clinical outcomes and radiographic fusion rates in anterior cervical discectomy and fusion: a systematic review
Isaac O Karikari, Deeptee Jain, Timothy Ryan Owens, et al.
Neuroimage. Clinical
|
November 2, 2013
Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions
Muireann Irish, Emma Devenney, Stephanie Wong, et al.
Mucosal Immunology
|
April 14, 2016
Lipoxin A<sub>4</sub> activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion
R R Hodges, D Li, M A Shatos, et al.
Mucosal Immunology
|
July 2, 2015
Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function
L García-Posadas, R R Hodges, D Li, et al.
Frontiers in Immunology
|
September 20, 2021
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
Fiona Bright, Jared S Katzeff, John R Hodges, et al.
Antimicrobial Agents and Chemotherapy
|
March 29, 2024
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants
Michael R Hodges, Susan Hazel, William G Kramer, et al.
JAMA Neurology
|
October 21, 2014
Quantifying the eating abnormalities in frontotemporal dementia
Rebekah M Ahmed, Muireann Irish, Jonathan Kam, et al.
Page
of 111